findmyKOL

Alexander Egbe, MPH

Enriched profile

Associate Professor of Cardiovascular Medicine · Mayo Clinic

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyCardiovascular DiseaseFocusCongenital Heart Disease Studies+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPaymentsNone reportedNIH funding2018–2026Why? →

Alexander Egbe is Associate Professor of Cardiovascular Medicine at Mayo Clinic. OpenAlex indexes 533 publications with 7,659 citations (h-index 44); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.

Data verified 17 Oct 2026

Overview

Updated 21 Oct 2026

Alexander Egbe is Associate Professor of Cardiovascular Medicine at Mayo Clinic, Rochester, Minnesota. The public record shows 533 publications with 7,659 citations (h-index 44), centered on Congenital Heart Disease Studies, Cardiac Valve Diseases and Treatments, Cardiovascular Function and Risk Factors. It also documents an investigator role on 10 registered clinical trials, 4 NIH-funded awards (2018–2026).

  • Most recent indexed publication: 2026 · Circulation. Heart failure
  • Top research focus: Congenital Heart Disease Studies
  • 10 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 21 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Defects, Congenital7 trialsHeart Failure1 trialAortic Coarctation1 trialTetralogy of Fallot1 trialPulmonary Hypertension

Research focus

OpenAlex concept fingerprint
Congenital Heart Disease StudiesCardiac Valve Diseases and TreatmentsCardiovascular Function and Risk FactorsAortic Disease and Treatment ApproachesPulmonary Hypertension Research and Treatments

Works with

trial sponsors and companies reporting payments
Mayo ClinicClinical trials10Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
533publications

Distinct works indexed by OpenAlex, matched via ORCID; 41 in PubMed.

7,659citations

Total citations across indexed works.

44h-index

Hirsch index (OpenAlex). i10-index 174.

Clinical & industry

trials, payments and federal funding
10clinical trials

Investigator role on registered studies.

View trials ↓
0companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
4NIH grants · 2018–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 21 Oct 2026

Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

No payments involving this person were reported to CMS in program years 2021–2024. Why? →

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    73.8%
    Beta blocker20.6%
    Metoprolol Succinate75%Carvedilol25%
    Part D<11 patients
    Aldosterone antagonist (MRA)14%
    Spironolactone100%
    Part D<11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    21%
    SGLT2 inhibitor15.9%
    Jardiance100%
    Part D<11 patients
    Potassium supplement5.1%
    Potassium Chloride100%
    Part D<11 patients
  • Blood & clotting

    5.1%
    Factor Xa inhibitor5.1%
    Eliquis100%
    Part D<11 patients
Where care is delivered (Part B)80.7% facility · 19.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 21 Oct 2026

4 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:

Publications

Updated 21 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 21 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Heidi M. Connolly294William R. Miranda209Christopher Charles Jain81Barry A. Borlaug64Omar A. Abozied53Yogesh N.V. Reddy45Luke James Burchill45Carole A. Warnes41Joseph A. Dearani39Abhishek J. Deshmukh37Snigdha Karnakoti37Jason H. Anderson36Marwan Ahmed34Naser M. Ammash33Patricia A. Pellikka32Malini Madhavan31Emmanuel O. Akintoye26Donald J. Hagler26Kartik Andi26Sorin V. Pislaru23Nathaniel W. Taggart23Elizabeth H. Stephens23Zeyad M. Kholeif23Ahmed Abdelmohsen Younis21Renuka Reddy Katta20Ahmed Goda20Ahmed Elsaid Ali19Arooj Razzaq Khan19Sameh M. Said18Samuel J. Asirvatham18Mohamed M. Ellabbad18Rahul Vojjini17Sara Elzalabany17Patrick S. Kamath16Maan Jokhadar16Keerthana Reddy Banala16Srikanth Reddy Kothapalli16Joseph T. Poterucha15Maria Najam15Vuyisile Tlhopane Nkomo15

Online presence

Updated 21 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    mayoclinic.elsevierpure.com/en/persons/alexander-egbe

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.elsevierpure.com ↗
  • Other

    mayo.edu/research/faculty/egbe-alexander-c-m-b-b-s-m-p-h/bio-20383570

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayo.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 21 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Guideline Committee Member

    2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.elsevierpure.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.